Welcome to our dedicated page for Dalrada Financl SEC filings (Ticker: DFCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Dalrada Financial Corporation’s disclosures span clean-energy heat pumps, cervical-cancer screening kits, and precision thin-film deposition systems—making each report a dense mix of engineering data, medical regulations, and climate-tech economics. If you have ever asked, “What does Dalrada report in its SEC filings?” or “Where can I find Dalrada’s quarterly earnings reports?”, you already know how complex these documents can be.
Stock Titan tackles that complexity head-on. Our AI parses every Dalrada annual report 10-K simplified section, flags segment revenue tied to low-carbon HVAC, and extracts FDA-related risk language from the healthcare division. Need mid-year numbers? The latest Dalrada quarterly earnings report 10-Q filing arrives here with plain-English revenue bridges, margin shifts, and heat-pump backlog metrics. Sudden news? The platform delivers Dalrada 8-K material events explained minutes after EDGAR posts.
Executive activity is equally transparent. Follow Dalrada insider trading Form 4 transactions and receive Dalrada Form 4 insider transactions real-time alerts outlining who bought or sold shares tied to new climate-tech contracts. For pay packages and voting matters, the Dalrada proxy statement executive compensation is broken down by our AI so you can compare stock options across segments. All this lives alongside:
- Dalrada executive stock transactions Form 4 history with trend charts
- Dalrada earnings report filing analysis that highlights segment EBIT swings
- Concise cheat-sheets for understanding Dalrada SEC documents with AI
Whether you are scanning cash-flow impacts of new heat-pump lines or verifying Deptec patent spending, you’ll find Dalrada SEC filings explained simply—updated in real time, organized by form type, and ready for deeper modelling.
Dalrada Financial Corporation (DFCO) reported fiscal Q1 2026 results for the quarter ended September 30, 2025. Total revenue was $4,098,786, down from $6,030,655 a year ago, with product sales weaker and services making up most of the quarter. Gross profit was $560,178 and the company posted a net loss of $6,063,068, similar to the prior year’s loss.
Operating expenses were $5,879,442. Cash used in operating activities was $4,216,845, offset by $4,521,215 of financing cash inflows, largely from related party notes. As of September 30, 2025, assets totaled $17,984,117 and liabilities were $30,582,753, resulting in a stockholders’ deficit of $12,598,636. Management disclosed negative working capital of $11,660,541 and “substantial doubt” about the company’s ability to continue as a going concern, citing reliance on collections from healthcare payers, heat pump sales, and subsidiary projects.
As of November 14, 2025, common shares outstanding were 120,157,113. Related party notes payable increased to $3,723,405. Deferred revenue reached $1,910,269, and contingent consideration remained $211,289.
Dalrada Technology Group, Inc. (f/k/a Dalrada Financial Corporation) reported that Chief Financial Officer Kyle McCollum resigned, effective immediately on October 31, 2025.
The company stated the resignation was not due to any disagreement regarding accounting practices, financial statements, or disclosures. Dalrada is identifying and appointing a successor and will provide updates in subsequent filings.
Dalrada Financial Corporation (DFCO) reports consolidated results showing revenue of $20.3 million for the year ended June 30, 2025 and a net loss before taxes of $(24.66) million, with net loss per common share to Dalrada stockholders of $(0.23) compared with $(0.31) in the prior year. The company recorded a goodwill impairment of approximately $2.7 million and disclosed a going concern qualification: negative operating cash flows raise substantial doubt about its ability to continue absent new equity or debt financing and improved cash collection from insurance payers, product sales and subsidiary operations.
At June 30, 2025 total assets include goodwill of $1.53 million and intangible assets of $3.11 million; total current liabilities include $15.74 million. Common shares outstanding were 120,157,113 as of September 29, 2025. The company completed multiple acquisitions (Grand Entrances, Genefic/IVS) and financed operations through related-party convertible preferred issuances and numerous notes payable; related-party debt conversions to Series I Preferred Stock and large warrant programs were noted. Lease and debt maturities and significant deferred tax assets are disclosed.
FAQ
What is the current stock price of Dalrada Financl (DFCO)?
What is the market cap of Dalrada Financl (DFCO)?
